Zentek Ltd. Receives Favorable Judgment in Long-Standing Litigation
Zentek clears legal hurdle and pivots toward high-value nuclear graphite as Nasdaq delisting clock ticks.
The most recent news (March 13, 2026) announces a major legal victory for Zentek. The Ontario Superior Court of Justice dismissed over $6 million in claims brought by the company’s founder and former CEO, Aubrey Eveleigh. The court denied claims for success fees, severance, and defamation, ruling that severance was unenforceable due to breaches of fiduciary duty. Simultaneously, Zentek is advancing its Albany Graphite Project, reporting that its material meets "nuclear-grade" purity standards (99.9992%), and has initiated a pilot program with Quality Filters Inc. to commercialize its ZenGUARD air filtration technology in the U.S.
The news is Material - Positive for three reasons: - Liability Elimination: The dismissal of $6M+ in legal claims removes a significant "dark cloud" and potential cash drain that represented nearly 50% of the company's current shareholders' equity. - Strategic Validation: The confirmation of "nuclear-grade" graphite (5N+ purity) shifts the Albany project from a generic battery-graphite play to a high-margin specialty material play, aligned with NATO and US Defense supply chain priorities. - Commercial Traction: The 8-12 week pilot with Quality Filters Inc. provides a low-capex pathway to the $7.3B U.S. air filtration market, moving away from the previous "build-it-ourselves" strategy. - However, the company remains under a Nasdaq deficiency notice (minimum $1.00 bid) with a deadline of August 24, 2026. While the news supports the share price, the risk of a reverse split or delisting remains if the price does not sustain above $1.00 for 10 consecutive days.
Zentek is an IP-development company specializing in graphene-based nanomaterials. - Flagship Project: The 100%-owned Albany Graphite Deposit in Northern Ontario. It is a unique igneous-hosted deposit that allows for high-purity (5N) processing without harsh halogen gases. - Core Platforms: - Albany Graphite: Targeting nuclear, battery anode, and defense sectors. - ZenGUARD: Antimicrobial coating for HVAC and PPE. - Triera Biosciences: Aptamer-based therapeutics (currently testing for H5N1/H1N1).